The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Enllaç al GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Enllaç al GIR
Cercador
ELS MÉS BUSCATS
COL·LABORA
Menú
English
Català
Español
Home
USR Barcelona
USR Barcelona
RESPONSABLE
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
Presentation
Team
Groups
Publications
Projectes
News
Presentation
Team
Groups
Publications
Projectes
News
Projectes
Group projects
Grup de recerca epidemiológica en Diabetis des de l’Atenció Primària de Catalunya (DAP.cat)
Principal investigators:
Josep Franch Nadal
Code:
7Z20/029
Start year:
2020
Funders:
ICS - Institut Català de la Salut
Global and country-specific rates and trends in the incidence of diagnosed type 2 diabetes (GLOBALDIAB)
Principal investigators:
José Manuel Mata Cases
Code:
4R22/320
Start year:
2022
Funders:
Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)
Characteristics and cardiovascular and mortality outcomes in patients with type 2 diabetes mellitus initiating treatment with sodium-glucose cotransporter- 2 inhibitors and other diabetic medications
Principal investigators:
Josep Franch Nadal
Code:
9F17/004
Start year:
2017
Funders:
AstraZeneca Farmacéutica Spain, S.A.
Feasibility Assessment for Drug Utilization Study in European Country Databases
Principal investigators:
Josep Franch Nadal
Code:
9F20/003
Start year:
2020
Funders:
Janssen Research & Development, LLC
ContRol de la diabEteS tipo 2 En tIempoS de pandemia COVID-19 en centros de aTención primaria. Estudio RESIST
Principal investigators:
Bogdan Vlacho Vlacho, Josep Franch Nadal
Code:
4R21/096
Start year:
2021
Funders:
Redgedaps, s.l.
Anterior
1
…
23
24
25
26
27
…
211
Següent